Cell Based Assay Market Latest Innovations, Drivers and Industry Status 2022 to 2028

Precision Business Insights published a research report on research report "Cell Based Assay Market: by Product Type (Consumables, Assay Kits, Reagents, Cell growth assay, Reporter gene assay, Immortalized cell lines, Stem cell lines, Primary cell lines, Others), by Application (ADME studies, Basic research, Predictive toxicology, Drug discovery, Other), by End user (Diagnostic Centres, Hospitals, Biopharmaceutical companies, Contract research organizations) and Geography)- Global/Region/Country Forecast to 2028", Cell based assay market size was valued at US$ 15.7 Billion in 2021 and is expected to grow at US$ 26.38 Billion at a CAGR rate of 7.9% till 2028 during the forecast period 2022-2028.

Glance our 200 slides market research and competitive intelligence research report, 25 Tables and 65 Figures and --other qualitative sections with an in-depth TOC on "Cell Based Assay Market: by Product Type (Consumables, Assay Kits, Reagents, Cell growth assay, Reporter gene assay, Immortalized cell lines, Stem cell lines, Primary cell lines, Others), by Application (ADME studies, Basic research, Predictive toxicology, Drug discovery, Other), by End user (Diagnostic Centres, Hospitals, Biopharmaceutical companies, Contract research organizations) and Geography)- Global/Region/Country Forecast to 2028"

View detailed Report Description at https://precisionbusinessinsights.com/market-reports/global-cell-based-assay-market/

Innovation of novel drugs is anticipated to drive the Cell Based Assay market
Analytical technique used for determining various parameters including cellular or biochemical functions of a living cell is called as cell-based Assay. This technique is also employed in the research process of novel drugs by making use of functional cells as diagnostic tools. Cell based Assay is performed in a number of therapeutic areas like immunology, cancer, stem cells and others. This technique is commonly used technique for measuring morphology, motility, toxicity and enzyme activity and cell proliferation in drug discovery and diagnostics. Abenex acquired the Cisbio BioAssay from Argos Soditic in July 2016 to develop its product collection.

The cell based assay market is in developing stage because of the growing research and development for novel drugs. A few more factors such as immunological disorders and increase in the occurrence of different cancer illnesses are projected to impel the growth of market. Key players in the market follow major strategies such as acquisitions, mergers, collaborations and novel product launches to boost the market share. For example, to optimize, validate and commercialize iPSC derived cell-based assay for the discovery of novel drug, Axiogenesis made collaboration with Metrion Biosciences Ltd in November 2016. Investment from different companies for the entry of startup organizations into the market and R&D activities also impel the growth of market.

Request sample report at https://precisionbusinessinsights.com/request-sample?product_id=16684

North America dominates the Cell Based Assay Market
North America anticipated to witness larger share in cell based assay market due to the increasing occurrence of chronic illnesses like cancer, innovation of new drugs, developed healthcare infrastructure and growing funding for the R&D activities. Europe also holds a considerable share in cell based assay market owing to increasing focus of biopharmaceutical companies on the innovation of novel products, change in lifestyle and increasing healthcare expenditure. Asia pacific market is also anticipated to experience considerable growth rate because of the factors such as growing development of novel drugs, increase in healthcare expenditure and growing investment by pharmaceutical companies. All these factors greatly contribute towards driving the cell based assay market over the evaluation time span.

Competitive Assessment - Cell Based Assay Market
Major players working in the cell based assay market are PerkinElmer Inc. (U.S.), GE Healthcare (U.K), ProQinase GmbH (Germany), Danaher Corporation (U.S.), Essen BioScience Inc. (U.S.), Lonza Group (U.S.), Thermo Fisher Scientific Inc. (U.S.), Abenex Capital SA (France), Axiogenesis AG (Germany) and Metrion Biosciences Ltd. (U.K.).

Contact:
Mr. Satya
Precision Business InsightsTM | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.